CDT EQUITY INC (CDT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CDT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of — · Company calendar date is not available
CDT — CEO transition
Dated 2026-09-01
CEO — James Bligh: James Bligh was appointed as CEO, continuing to serve as CFO and Director, indicating an internal promotion or role expansion rather than a departure.
Why it matters: Submitting the plan on time is crucial for maintaining the Nasdaq listing. Failure to comply could lead to delisting.
Supportive ifThe company submits a compliance plan to Nasdaq by the deadline of July 20, 2026.
Worry ifThe company fails to submit the compliance plan by July 20, 2026.
Why it matters: Using the equity line of credit can give needed funds. It shows financial plans.
Supportive ifCDT announces the drawdown of funds from the equity line of credit facility.
Worry ifCDT fails to utilize the equity line of credit despite ongoing financial needs.
Why it matters: Changing auditors can change how they report money. It might also affect rules they follow.
Worry ifThe new auditor gives a clean audit report. This is for the upcoming financial statements.
Less concerning ifThe new auditor raises concerns. It may issue a qualified audit report.
Why it matters: The company got a Nasdaq letter. It was for not filing its quarterly report. This affects its listing.
Worry ifThe company files its Q2 report on time. It fixes the deficiency letter.
Less concerning ifThe company does not file its Q2 report. It may get more delisting notices.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$711 on $10,000 · ±7.1% | How much price usually moves either way. |
| Bad day | $2,235 loss on $10,000 · 22.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,997 loss on $10,000 · 100.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Using the equity line can help with cash flow. It supports operations and growth.
Supportive ifThe company announces it will draw from the equity line of credit.
Worry ifThe company does not use the equity line. It faces cash flow problems.
Why it matters: A new auditor can mean changes in financial checks and reports.
Watch forThe new auditor gives a clean opinion on CDT's financials.
Also watch forThe new auditor raises concerns or issues in their audit report.
Why it matters: Continued improvements in debt management can strengthen the balance sheet. This is key for future growth.
Supportive ifThe company says it has reduced debt or secured better terms on new loans.
Worry ifThe company reports new debt issues or fails to meet obligations.
Why it matters: Ongoing legal issues could affect CDT's operations and finances. Updates will show how management deals with these risks.
Worry ifCDT says it has fixed ongoing legal or regulatory problems.
Less concerning ifCDT announces new legal or regulatory issues that make things worse.
Why it matters: Ongoing litigation could impact CDT's financial health and operations. Investors need to know the risks.
Worry ifA good ruling or settlement that lowers risks from lawsuits.
Less concerning ifA bad ruling that raises financial risks or limits operations.
Why it matters: This loan is key for CDT's working capital and strategic goals. Positive updates would signal financial stability.
Supportive ifCDT successfully draws down the remaining balance of the $1.46M loan from JJ Astor.
Worry ifCDT fails to meet conditions for further funding from JJ Astor.
Why it matters: The reverse stock split aims to boost the share price for compliance. A positive market reaction could indicate investor confidence.
Supportive ifThe stock price stabilizes or increases after the reverse stock split on July 20, 2026.
Worry ifThe stock price declines significantly after the reverse stock split.
Why it matters: Ongoing lawsuits could hurt the company's operations. They may also affect its finances.
Worry ifThe company has settled important lawsuits. This is a big step for them.
Less concerning ifNew lawsuits are filed or existing ones worsen. This will raise legal costs.
Why it matters: Meeting conditions for the new loan is vital for CDT's working capital and strategic goals. Failure could impact operations.
Supportive ifCDT successfully meets all conditions for the $1.46 million loan agreement by the end of July 2026.
Worry ifCDT fails to meet conditions for the loan agreement, impacting working capital.
Why it matters: Lawsuits may impact how CDT runs its business and its finances.
Worry ifCDT says it has resolved ongoing lawsuits.
Less concerning ifNew lawsuits are filed against CDT. This raises legal risks.
Why it matters: Litigation risks can hurt CDT's operations. Updates will show how management is handling these issues.
Worry ifManagement will give a clear update on litigation risks during the earnings call on August 13, 2026.
Less concerning ifManagement does not talk about legal risks. They give poor updates during the earnings call.
Why it matters: The reverse stock split aims to maintain Nasdaq listing compliance. A significant drop in share price could indicate ongoing investor concerns.
Worry ifCDT's share price remains above $1.00 after the reverse stock split on July 20, 2026.
Less concerning ifCDT's share price falls below $1.00 after the reverse stock split.
Why it matters: Filing the 10-Q is crucial for regaining compliance with Nasdaq. Failure to file could lead to delisting.
Worry ifCDT files its 10-Q by July 20, 2026, as planned.
Less concerning ifCDT fails to file the 10-Q by the deadline, leading to potential delisting.
Why it matters: Successful M&A can help CDT grow and increase value for shareholders. Ongoing M&A shows the company is making progress.
Supportive ifCDT will announce more successful acquisitions or partnerships in the next quarter.
Worry ifCDT fails to secure new M&A deals or partnerships, indicating stagnation.
Why it matters: Improving CDT's debt can make its balance sheet stronger and give it more flexibility.
Supportive ifCDT will share news about paying off debt. They may also change their debt structure to lower what they owe.
Worry ifCDT reports higher debt levels or new financing needs.